source
- Lilly showcases Jaypirca combination data in CLL at EHA26, debuting results from Ajax acquisitionEli Lilly highlighted new blood‑cancer data at the European Hematology Association meeting in Stockholm. The company presented early clinical results for its Jaypirca therapy combined with the stan…
- Six Biopharma Leaders Drive LGBTQ+ Inclusion Amid Rising Anti-LGBTQ LegislationSix executives are spearheading initiatives to improve LGBTQ+ inclusion across the biopharmaceutical sector. Their work focuses on creating supportive policies, training programs, and community out…